Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
D001853:Bone Marrow / Q000378:metabolism; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007938:Leukemia / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000378:metabolism*; D007951:Leukemia, Myeloid / Q000378:metabolism*; D008297:Male; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013767:Tetrahydrouridine / Q000494:pharmacology / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism
D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D003561:Cytarabine; D013767:Tetrahydrouridine; D013936:Thymidine